Monitoring of Incidence of Mental Discomfort in Pregnant Women During the Serious COVID-19 Pandemic Conditions
NCT ID: NCT04898192
Last Updated: 2021-05-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1500 participants
OBSERVATIONAL
2021-04-01
2022-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic
NCT04377412
Birth Experience During COVID-19 Confinement
NCT04348929
Pregnancy Without Psychosocial Stress
NCT04853693
Exposures to Perinatal Adverse Experiences: Multimodal Omics Signature of Stress Vulnerability and Resilience and Preventive Strategies
NCT05951738
Stress in Pregnancy During the Covid19 Pandemic and Impact on the Newborn Neurodevelopment
NCT06362486
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Following questionnaires are planned to be used in the study:
* Wijma Delivery Expectancy/Experience Questionnaire - aimed at fear of delivery
* PASS (Perinatal Anxiety Screening Scale) - aimed at anxiety in women before and after delivery
* PHQ-9-SK (Patient Health Questionnaire) - aimed at depressive disorder
* HITS Domestic Violence Screening Tool - aimed at domestic violence
* DOK (The Obsessive-Compulsive Inventory) - aimed at obsessive and compulsive symptoms
* GAD-7 (General Anxiety Disorder-7) - aimed at general anxiety disorder
* EPDS (Edinburgh Postnatal Depression Scale) - aimed at symptoms of postpartal depression
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
questionnaire - the complex of 6 questionnaires aimed to recognize the fear of delivery, perinatal anxiety, depressive disorder, obsessive-compulsive disorder, general anxiety disorder, postpartal depression and domestic violence.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Vital fetus
Exclusion Criteria
* Age less than 18 years
* Foetus mortus or perinatal death of the newborn
* Low knowledge of Slovak language
* Serious pathology in the pregnancy (e.g. placenta praevia, known congenital disorders)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Comenius University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Musil
head of project centre Faculty of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jozef Zahumensky, prof. MD
Role: STUDY_CHAIR
Comenius University in Bratislava
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
2nd Department of Obstetrics and Gynecology, University Hospital Bratislava and Comenius University, Bratislava, Slovak Republic
Bratislava, Slovensko, Slovakia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EC/045/2021/UNBRuzinov
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.